Screen shot. Only two events. Immutep is up for PDUFA alongside BMS’s Relatlimab. Provisional approval for Efti?
The phase2b was potentially a registrational trial of the highest standard. The blockbuster results in under 65’s and low monocytes would be too good to delay release, imo. There’s already enough trial evidence there are no side effects and the quality and length of life is significantly improved in a patient group with no options. It’s a lay down they will want to release Efti into MBC patients asap, imo, on a provisional basis.
Get in quick. we are going to the moon.
Screen shot. Only two events. Immutep is up for PDUFA alongside...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.3¢ |
Change
-0.003(0.88%) |
Mkt cap ! $406.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $964.2K | 3.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 497337 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 395119 | 33 |
View Market Depth
| Last trade - 14.33pm 04/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |